Review Article: Psychopharmacologic Treatment in Neurological Practice

Abstract

References

Weissman MM , Merikangas KR , Boyd JH Epidemiology of affective disorders. In: Midiels R , Cavendar JO , Brodie HKH , et al, eds. Psychiatry. Philadelphia: Lippencott, 1985;1:1-11.

Robinson RG , Lipsey JR , Price TP Diagnosis and clinical management of post-stroke depression. Psychosomatics 1985;26:769-78.

Robinson RG Post-stroke mood disorders. Hosp Practice 1985;26:769-78.

Folstein F. , Mailberger R. , McHugh R. Mood disorder as a specific complication of stroke. J Neurol Neurosurg Psychiatry 1977;4:72-94.

Reding MJ , Orto LA , Winter SW , Fortuna IM , et al. Antidepressant therapy after stroke. A double-blind trial. Arch Neurol 1985;43:763-5.

Medical Letter : Drugs that cause psychiatric symptoms. Med Lett 1985;26:75-8.

Dubovsky SL , Weissberg MP Clinical psychiatry in primary care (3rd ed). Baltimore: Williams and Wilkins , 1986.

Ross ED , Rush AJ Diagnosis and neuroanatomical correlates of depression in brain damaged patients . Arch Gen Psychiatry 1981;38:1344-54.

Goodman WK , Charney DS Therapeutic applications and mechanisms of action of monoamine oxidase and heterocyclic antidepressant drugs. J Clin Psychiatry 1985;46:6-22.

10.

Fiori MG Tricyclic antidepressants: a review of their toxicity. Curr Dev Psychopharmacol 1977;4:72-94.

11.

Baldessarini RJ Drugs and the treatment of psychiatric disorders . In: Gilman AG , Goodman LS , Rall TW , et al, eds. The pharmacological basis of therapeutics. New York: Macmillan, 1985:387-445.

12.

Demuth GW , Breslov RE , Drescher J. The elicitation of a movement disorder by trazodone: Case report. J Clin Psychiatry 1985;46:535-6.

13.

Krummel SJ , Wesner RB Exacerbation of acute intermittant prophyria by nortriptyline. Drug Intell Clin Pharm 1986;20:487-8.

14.

Huang CC

Persistent tardive dyskinesia associated with amoxapine therapy. Am j

Psychiatry 1986;143: 1069-70.

15.

Richelson E. The newer antidepressants: structures, pharmacokinetics, pharmacodynamics, and proposed mechanisms of action. Psychopharmacol Bull 1984; 20:213-23.

16.

Bakish D. , Lapierre Y. Myalgia with new generation antidepressants. J Clin Psychopharmacol 1986;6: 195-6.

17.

Lydiard RB Tricyclic-resistant depression: treatment resistance of inadequate treatment . J Clin Psychiatry 1985;46:412-17.

18.

Rubin EH , Biggs JT , Preskom SH Nortriptyline pharmacokinetics and plasma levels: implications for clinical practice. J Clin Psychiatry 1985;46:418-24.

19.

Task Force on the Use of Laboratory Tests in Psychiatry. Tricyclic antidepressants: blood level measurements and clinical outcome. Am J Psychiatry 1985;142:155-62.

20.

Prien RF , Kupfer DJ Continuation drug therapy for major depressive episodes: how long should it be maintained. Am J Psychiatry 1986 ;143:18-23.

21.

Lawrence JM Reactions to withdrawal of antidepressants, antiparkinsonian drugs, and lithium. Psychosomatics 1985;11:869-77.

22.

Kaufman MW , Cassem N. , Murray G. , et al. The use of methylphenidate in depressed patients after cardiac surgery. J Clin Psychiatry 1984;45:82-4.

23.

Dubovsky SL Using electroconvulsive therapy in patients with neurological disease. Hosp Commun Psychiatry 1986;37:819-25.

24.

Salzman C. Clinical guidelines for the use of antidepressant drugs in geriatric patients . J Clin Psychiatry 1985;46:38-44.

25.

Pinder RM , Brogdon RN , Speight TM , et al. Maprotiline: a review of its pharmacological properties and therapeutic efficacy in mental states. Drugs 1977;13: 321-52.

26.

Wender PH , Kety SS , Rosenthal D. , et al. Psychiatric disorders in the biological and adoptive families of adopted individuals with affective disorders. Arch Gen Psychiatry 1986;43:923-9.

27.

Litovitz TL , Troutman WG Amoxapine overdose: seizures and fatalities . JAMA 1983;250:1069-71.

28.

Tasini M. Complex partial seizures in a patient receiving trazodone. J Clin Psychiatry 1986;47:318-19.

29.

Santamaria J. , Tolosa E. , Valles A. Parkinson's disease with depression: a possible subgroup of idiopathic parkinsonianism. Neurology 1986;36:1130-3.

30.

Harvey NS Psychiatric disorders in parkinsonism: 2. Organic cerebral states and drug reactions. Psychosomatics 1986;27:175-82.

31.

Ayd FJ

Antidepressant drug therapy for depressed parkinsonian patients. International Drug Therapy

Newsletter 1986;121:5-6.

32.

Ananth J. Choosing the right antidepressant. Psychiatr J Univ (Ottawa) 1983;8:20-6.

33.

Sheehan DV , Shaw KR When, how and which antidepressants to prescribe for anxiety disorders. Int Drug Ther Newsletter 1986;21:33-6.

34.

Patt N. More on trazodone and priapism. Am J Psychiatry 1985;142:788-9.

35.

Schiffer RB , Hemdon RM , Rudide RA Treatment of pathological laughing and weeping with amitriptyline. N Engl J Med 1985;312:1480-2.

36.

Rosenblatt RM , Reich J. , Dehrung D. Tricyclic antidepressants in treatment of depression and chronic pain: analysis of the supporting evidence . Anesth Analg 1984;63:1025-32.

37.

Hoogiverf B. Amitriptyline treatment of painful diabetic neuropathy: an inadvertent single-patient clinical trial. Diabetes Care 1985;8:526-7.

38.

Mendel CM , Klein RF , Chappell DA , Dere WH , et al. A trial of amitriptyline and fluphenazine in the treatment of painful diabetic neuropathy. JAMA 1986;255: 637-9.

39.

Simmel GL , Escobar JI Antidepressants in chronic pain: A review of efficacy. Pharmacotherapy 1986;6: 262-7.

40.

Mathew NT Prophylaxis of migraine and mixed headache: a randomized controlled study . Headache 1981;21:105-9.

41.

Stalnikowicz R. , Fich A. Amitriptyline for intractable hiccups . N Engl J Med 1986;315:64-5.

42.

Graham LF , Fredricson-Overo K. , Kirk L. Influences of neuroleptics and benzodiazepines on metabolism of tricyclic-antidepressants in man. Am J Psychiatry 1974;131:863-6.

43.

Bernstein JG Handbook of drug therapy in psychiatry. Boston: John Wright-PSG, 1983.

44.

Harvey SC Hypnotics and sedatives. In: Gilman AG, Goodman LS, Rall TW, et al. The pharmacological basis of therapeutics (7th ed). New York: MacMillan, 1985:339-71.

45.

Dom JM A case of phenytoin toxicity possibly precipitated by trazodone. J Clin Psychiatry 1986;47:89-90.

46.

Quitkin F. , Rifkin A. , Klein DF Monoamine oxidase inhibitors: Review of effectiveness . Arch Gen Psychiatry 1979;36:749-60.

47.

McGrath PJ , Steward JW , Harrison W. , Wagner S. , Quitkin FM Phenelzine treatment of melancholia. J Clin Psychiatry 1986;47:420-2.

48.

Sheehan DV , Ballenger J. , Jacobson G. Treatment of endogenous anxiety with phobid, hysterical, and hypochondriacal symptoms. Arch Gen Psychiatry 1980;37:50-1.

49.

Pare Cmb. The present status of monoamine oxidase inhibitors. Br J Psychiatry 1985;146:576-84.

50.

Klein DF , Gittleman R. , Quitkin F. , et al. Diagnosis and drug treatment of psychiatric disorders: adults and children (2nd ed). Baltimore : Williams and Wilkins, 1980.

51.

Kayser A. , Robinson DS , Nos A. , Howard D. Response to phenelzine among depressed patients with features of hysteroid dysphoria. Am J Psychiatry 1985;142: 486-8.

52.

Robinson DS , Cooper TB , Jundal SP , Corcella J. , Lutz T. Metabolism and pharmacokinetics of phenelzine: lack of evidence for acetylation pathway in humans. J Clin Psychopharmacol 1985;5:333-8.

53.

Patterson JF Metoclopramide therapy of MAOI orthostaic hypotension (letter to editor). J Clin Psychopharmacol 1987;7:112-3.

54.

Lieberman JA , Kane JM , Reife R. Neuromuscular effects of monoamine oxidase inhibitors. J Clin Psychopharmacol 1985;5:217-20.

55.

Meyler L. , Herxheimer A. Side effects of drugs. Baltimore: Williams and Wilkins, 1968.

56.

Tabakoff B. , Lee JM , DeLeon-Jones L. , et al. Ethanol inhibits the activity of the B form of monoamine oxidase in human platelet and brain tissue. Psychopharmacology 1985;87:152-6.

57.

Jenike MA The use of monoamine oxidase inhibitors in the treatment of elderly patients . J Am Geriatr Soc 1984;32:571-5.

58.

Lewin R.

Clinical trial for Parkinson's disease?

Science 1985;243:527-8.

59.

Hansten PD Drug interactions (5th ed). Philadelphia: Lea and Febiger, 1985 .

60.

Sandyk R. L-dopa induced serotonin syndrome in a Parkinsonian patient on bromocriptine . J Clin Psychopharmacol 1986;6:194-8.

61.

Baloh RW Myoclonus and ocular oscillations induced by L-tryptophan. Ann Neurol 1982;11:95-7.

62.

Roy A. , Pickar D. Lithium potentiation of imipramine in treatment-resistant depression . Br J Psychiatry 1985;148:582-3.

63.

Garbutt JC , Mayo JP , Gillette GM , et al. Lithium potentiation of tricyclic antidepressants following lack of t3 potentiation. Am J Psychiatry 1986 ;143: 1038-9.

64.

Price LH , Charney DS , Heninger GR Efficacy of lithium-tranylcypromine treatment in refractory depression . Am J Psychiatry 1985;142:619-23.

65.

Jefferson JW , Griest JH Primer of lithium therapy. Baltimore: Williams and Wilkins, 1977.

66.

Franks RD , Dubovsky SL , Lifschitz M. , et al. Long term lithium carbonate therapy causes hyperparathyroidism . Arch Gen Psychiatry 1982;39:1074-7.

67.

Yassa R. Hair loss during lithium therapy. Am J Psychiatry 1986;143:943.

68.

Saul RF Pseudotumor cerebri secondary to lithium carbonate. JAMA 1975;253:2869-71.

69.

Uhde TW , Post RM , Ballenger JC , et al. Carbamazepine in the treatment of neuropsychiatric disorders . In: Emrich HM , Okuma T , Muller AA , eds. Anticonvulsants in affective disorders. Amsterdam: Elsevier Science Publishers, 1984.

70.

Dubovsky SL

Calcium antagonists: A new class of psychiatric drugs?

Psychiatr Ann 1986;16:724-8.

71.

Chouinard G. , Young SM , Annable L. Antimanic effects of clonazepam. Biol Psychiatry 1983;18:451-66.

72.

Chouinard G. , Penry JK Neurologic and psychiatric aspects of clonazepam: an update: proceedings of a symposium. Psychosomatics 1985;26(Suppl):1-37.

73.

Telner JL , Lapieire YD , Horn E. , et al. Rapid reduction of mania by means of reserpine therapy. Am J Psychiatry 1986;143:1058.

74.

Jobling M. , Stein G. Lorazepam in resistant mania. Lancet 1986;1:5-10.

75.

Modell JG In patient clinical trial of lorazepam for the management of manic agitation . J Clin Psychopharmacol 1985;5:109-13.

76.

Dubovsky SL , Franks RD , Allen S. , Murphy J. Calcium antagonists in mania: a double-blind study of verapamil. Psychiatry Res 1986;18:309-20.

77.

Caillard V. Treatment of mania using a calcium antagonist: preliminary trial. Neuropsychobiology 1985 ;14:23-6.

78.

Massey EW , Folger WM Seizures activated by therapeutic levels of lithium carbonate. South Med J 1984;77:1173-5.

79.

Kane JM , Rifkin A. , Quitkin F. , Klein DF Extrapyramidal side effects with lithium treatment. Am J Psychiatry 1978;135:851-3.

80.

Brauchey MH , Charles J. , Simpson GM Extrapyramidal side effects in lithium maintenance therapy. Am J Psychiatry 1976;133:444-5.

81.

Shopsin B. , Gershon S. Cogwheel rigidity related to lithium maintenance. Am J Psychiatry 1975;132: 536-8.

82.

Dubovsky SL , Franks RD , Allen S. Verapamil: a new antimanic drug with potential interactions with lithium. J Clin Psychiatry (in press).

83.

Martin CA , Piascik MT First degree A-V block in patients on lithium carbonate. Can J Psychiatry 1985;30:114-30.

84.

Singer I. , Rotenberg D. Mechanisms of lithium action. N Engl J Med 1973;289:254-60.

85.

Quinn N. , Marshden CD Lithium for painful dystonia in Parkinson's disease. Lancet 1986;1:494-7.

86.

Cohen WJ , Cohen NH Lithium carbonate, haloperidol and irreversible brain damage. JAMA 1974;230: 1283-7.

87.

Prakash R. , Kelwala S. , Ban TA Neurotoxocity with combined administration of lithium and a neuroleptic. Compr Psychiatry 1982;23:567-71.

88.

Goldney RD , Spence ND Safety of the combination of lithium and neuroleptic drugs. Am J Psychiatry 1986;143:882-4.

89.

Izzo KL , Brody R. Rehabilitation in lithium toxicity. Arch Phys Med Rehabil 1985;66:779-82.

90.

Addonizio G. Rapid induction of extrapyramidal side effects with combined use of lithium and neuroleptics. J Clin Psychopharamacol 1985;5:296-8.

91.

Miller F. , Menninger J. , Whitcup SM Lithium-neuroleptic neurotoxicity in the elderly bipolar patient. J Clin Psychopharmacol 1986;6:176-7.

92.

Miller F. , Menninger J. Lithium-neuroleptic neurotoxicity is dose related. J Clin Psychopharmacol 1987;7: 89-91.

93.

Baptista T. Lithium-neuroleptic combination and irreversible brain damage. Acta Psychiatrica Scand 1986 ;73:111-15.

94.

Kane JM Doseage strategies with long-acting injectable neuroleptics, including haloperidol decanoate. J Clin Psychopharmacol 1986;6:205-35.

95.

Davis JM , Andriukaitis S. The natural course of schizophrenia and effective maintenance drug treatment . J Clin Psychopharmacol 1986;6:25-105.

96.

Escobar JI , Barron A. , Kiriakos R. A controlled study of "neuroleptization" with fluphenazine hydrochloride injections . J Clin Psychopharmacol 1983;3:359-63.

97.

Coffman JA , Nasrallah HA , Lyskowski J. , et al. Clinical effectiveness of oral and parenteral rapid neuroleptization . J Clin Psychiatry 1987;48:20-4.

98.

Modestin J. , Toffler G. , Pia M. Haloperidol in acute schizophrenic inpatients: a double-blind comparison of two dosage regimens . Pharmacopsychiatry 1983; 16:121-6.

99.

Ko GN , Korpi ER , Linoila M. On the clinical relevance and methods of quantification of plasma concentrations of neuroleptics. J Clin Psychopharmacol 1985 ;5: 253-62.

100.

Tesar GE , Murray GB , Cassem VH Use of high-dose intravenous haloperidol in the treatment of agitated cardiac patients. J Clin Psychopharmacol 1985 ;5: 344-7.

101.

Adams F. , Ferdanez F. , Anderson BE Emergency pharmacotherapy of delirium in the critically ill cancer patient . Psychosomatics 1986;27(Suppl):33-7.

102.

Ay, F.

Intravenous haloperidol-lorazepam therapy of delirium. International Drug Therapy

Newsletter 1984;19:33-5.

103.

Winslow RS , Stellner V. , Coons DJ , Robinson MW Prevention of acute dystonic reactions in patients beginning high-potency neuroleptics. Am J Psychiatry 1986;143:706-10.

104.

Ayd F.

Prophylactic antiparkinson drug therapy: pros and cons. International Drug Therapy

Newsletter 1986;121:5-6.

105.

Manos N. Lavrentuades G. , Gkiouzepas J. Evaluation of the need for prophylactic anti-parkinsonian medication in psychotic patients treated with neuroleptics. J Clin Psychiatry 1986;47:114-16.

106.

McEvoy JP The clinical use of anticholinergic drugs as treatment for extrapyramidal side effects of neuroleptic drugs. J Clin Psychopharmacol 1983 ;3:288-302.

107.

Correa N. , Opler LA , Kay SR , Birmaher B. Amantadine in the treatment of neuroendocrine side effects of neuroleptics . J Clin Psychopharmacol 1987;7.91-5.

108.

Baldessarini RJ Clinical and epidemiological aspects of tardive dyskinesia. J Clin Psychiatry 1985;46(4, sec.2):8-13.

109.

Gee S. , Mesard L. Psychiatric Drug Study, Part I. Psychiatric Ward/Unit Study. Office of the Controller, Monograph No. 9, Washington, D.C., U.S. Veterans Administration, 1979.

110.

Kane JM , Woemer M. , Borenstein M. , et al. Integrating incidence and prevalence of tardive dyskinesia. Paper presented at the 4th World Congress of Biological Psychiatry , Philadelphia, 8-13 September 1985 .

111.

Kane JM , Smith JM Tardive dyskinesia: prevalance and risk factors. Arch Gen Psychiatry 1982 ;39:473-81.

112.

Jeste DV , Wyatt RJ Prevention and management of tardive dyskinesia. J Clin Psychiatry 1985;46(4, sec.2): 14-18.

113.

Gardos G. , Cole JO Tardive dyskinesia an anticholinergic drugs. Am J Psychiatry 1985;46(4, sec.2):8-13.

114.

Fahn S. A therapeutic approach to tardive dyskinesia. J Clin Psychiatry 1985;46(4, sec.2):19-24.

115.

Casey D. Clinical and laboratory studies of tardive dyskinesia. J Clin Psychiatry 1985;46(4, sec.2):42-7.

116.

Klawans HL , Carvey P. , Tanner CM , Goetz CG The pathophysiology of tardive dyskinesia . J Clin Psychiatry 1985;46(4, sec.2):38-41.

117.

Cadet JL , Braun T. , Grebb JA , Freed WJ Effect of verapamil in an animal model of dyskinesia. Neurology 1986;36(Suppl. 1):342.

118.

Barrow N. , Childs A. An anti-tardive dyskinesia effect of verapamil. Am J Psychiatry 1986;143:1485.

119.

Bacher NM , Lewis HA Low-dose propranolol in tardive dyskinesia. Am J Psychiatry 1980;137:495-7.

120.

Freedman R. , Bell J. , Kirch D. Clonidine therapy for coexisting psychosis and tardive dyskinesia. Am J Psychiatry 1980 ;137:629-30.

121.

Caroff SN The neuroleptic malignant syndrome. J Clin Psychiatry 1980;41:79-83.

122.

Kurlan R. , Hammill R. , Shoulson I. Neuroleptic malignant syndrome. Clin Neuropharmacol 1984;7:109-20.

123.

Guze BH , Baxter LR Neuroleptic malignant syndromes. N Engl Med 1985;313:163-6.

124.

Pearlman CA Neuroleptic malignant syndrome: a review of the literature. J Clin Psychopharmacol 1986 ;6:257-73.

125.

Levinson DF , Simpson GM Neuroleptic-induced extrapyramidal symptoms with fever. Arch Gen Psychiatry 1986 ;43:839-48.

126.

Addonizio G. , Susman VL , Roth SD Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients. Am J Psychiatry 1986;143:1587-90.

127.

Meuller PS Neuroleptic malignant syndrome. Psychosomatics 1985;26:654-62.

128.

Pelonera AL , Levinson JL , Silverman JL Neuroleptic therapy following neuroleptic malignant syndrome. Psychosomatics 1985;26:946-7.

129.

Hamburg P. , Weilburg JB , Carsem NH , Cohen L. , Brown S. Relapse of neuroleptic malignant syndrome with early discontinuation of amantadine therapy. Compr Psychiatry 1986;27:272-5.

130.

Arana GW , Goff DC , Friedman H. , et al. Does carbamazepine-induced reduction of plasma haloperidol levels worsen psychotic symptoms? Am J Psychiatry 1986;143:650-1.

131.

Kanter GL , Yerevanian BI , Ciccone JR Case report of a possible interaction between neuroleptics and carbamazepine . Am J Psychiatry 1984;141:1101-2.

132.

Ward ME , Saklad SR , Ereshefsky L. Lorazepam for the treatment of psychiatric agitation. Am J Psychiatry 1986;143:1195-6.

133.

Bick PA , Hannah AL Intramuscular lorazepam to restrain violent patients (letter to editor) . Lancet 1986;1:206.

134.

Salzman C. , Green AI , Rodriguez-Villa F. , et al. Benzodiazepines combined with neuroleptics for management of severe disruptive behavior. Psychosomatics 1986;27(Suppl.):17-21.

135.

Richelson E. Pharmacology of neuroleptics in use in the United States. J Clin Psychiatry 1985;48:8-14.

136.

Berlant JL Neuroleptics and reserpine in refractory psychoses . J Clin Psychopharmacol 1986;6:180-4.

137.

Yudofsky S. , Williams D. , Gorman J. Propranolol in the treatment of rage and violent behavior in patients with chronic brain syndrome. Am J Psychiatry 1983;138:218-20.

138.

Silver JM , Yudofsky S.

Propranolol for aggression: literature review and clinical guidelines. International Drug Therapy

Newsletter 1985 ;20:9-12.

139.

Mattes JA Propranolol for adults with temper outbursts and residual attention deficit disorder. Clin Psychopharmacol 1986 ;6:299-302.

140.

Simpson DM , Foster D. Improvement in organically disturbed behavior with trazadone treatment. J Clin Psychiatry 1986;47:191-3.

141.

Raskin DE Antipsychotic medication and the elderly. J Clin Psychiatry 1985;46:36-40.

142.

American Psychiatric Association. Diagnostic and statistical manual of mental disorders (3rd ed). Washington, D.C., American Psychiatric Press, 1980.

143.

Charney DS , Woods SW , Goodman WK , Rufkin B. , et al. Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone. J Clin Psychiatry 1986;47:580-6.

144.

Spier SA , Tesar GE , Rosenbaum JF , et al. Treatment of panic disorder and agoraphobia with clonazepam . J Clin Psychiatry 1986;47:238-42.

145.

Beaudry P. , Fontaine R. , Chouinard G. , Annable L. Clonazepam in the treatment of patients with recurrent panic attacks . J Clin Psychiatry 1986;47:83-5.

146.

Griffiths RR , Ator N. Benzodiazepine self-administration in animals and humans: A comprehensive literature review. In: Ludford J , Szara S , eds. Benzodiazepines, Washington, D.C., Gov't Printing Office, 1981. (DHHS publ. #ADM 81-10521).

147.

Greenblatt DJ , Shader RI , Abernathy DR Current status of benzodiazepines . N Engl J Med 1983;309: 354-8.

148.

Busto U. , Sellers EM , Naranjo CA , et al. Patterns of benzodiazepine abuse and dependence. Br J Addict 1986;81:87-94.

149.

Dommisse CS , DeVane CL Buspirone: a new type of anxiolytic . Drug Intell Clin Pharm 1985;19:624-8.

150.

Taylor DP , Eison MS , Riblet LA , Vandermaelen CP Pharmacological and clinical effects of buspirone. Pharmacol Biochem Behav 1985;23:687-94.

151.

Colin JB , Walcox CS Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: A double-blind study. J Clin Psychiatry 1986;47:409-12.

152.

Foster FB , Kupfer DJ , Coble P. , et al. Rapid eye movement sleep-density: An objective indicator in severe medical-depressive syndromes. Arch Gen Psychiatry 1976;33:1119-23.

153.

Coble P. , Foster FG , Kupfer DJ Electroencephalographic sleep diagnosis of primary depression. Arch Gen Psychiatry 1976;33:1124-7.

154.

Mendels J. , Schless AP Comparative efficacy of alprozolam, imipramine and placebo administered once a day in treating depressed patients . J Clin Psychiatry 1986;47:357-61.

155.

Buston U. , Sellers EM , Naranjo CA , et al. Withdrawal reaction after long-term therapeutic use of benzodiazepines . N Engl J Med 1986;315:854-9.

156.

Winokur A. , Rickels K. , Greenblatt DJ , et al. Withdrawal reaction from long-term, low-dosage administration of diazepam: A double-blind placebo-controlled case study. Arch Gen Psychiatry 1980;37: 101-5.

157.

Vyas I. , Chamey Mwp , Diazepam withdrawal fits. Br Med J 1975;4:44.

158.

Soldatos CR , Sakkas PN , Bergrannaki JD , et al. Behavioral side effects of triazolam in psychiatric inpatients: report of five cases. Drug Intell Clin Pharmacol 1986;20:294-7.

159.

Klein E. , Uhde TW , Post RM Preliminary evidence for the utility of carbamazepine in alprozolam withdrawal . Am J Psychiatry 1986;143:235-6.

160.

Ayd F. Buspirone: a review. International Drug Therapy Newsletter 1984;19:37-42.

161.

Smith DE , Wesson DR A new method for treatment of barbiturate dependence. JAMA 1970;213:294-5.

162.

Tesar GE , Rosenbaum JF Successful use of clonazepam in patients with treatment-resistant panic disorder . J New Ment Dis 1986;174:477-82.

163.

Pollack MH , Tesar GE , Rosenbaum JF , Spier SA Clonazepam in the treatment of panic disorder agoraphobia: A one-year follow-up. J Clin Psychopharmacol 1986;6:302-4.

164.

Bouckonis AJ , Litman RE Clonazepam in the treatment of neuralgic pain syndromes. Psychosomatics 1985 ;26:933-6.

165.

Larsen S. , Telstad W. , Sorenson O. , et al. Carbamazepine therapy in restless legs: discrimination between responders and nonresponders. Acta Med Scand 1985;218:223-7.

166.

Stewart MM MAOIs and food—fact and fiction. Adverse Drug Reaction Bull 1976;58:200-3.

167.

Sullivan EA , Shulman KI Diet and monoamine oxidase inhibitors: a reexamination . Can J Psychiatry 1984;29:707-11.